Endocrinol Metab.  2015 Mar;30(1):47-52. 10.3803/EnM.2015.30.1.47.

Articles in 'Endocrinology and Metabolism' in 2014

• Lee WY

• KMID: 2407103
• DOI: http://doi.org/10.3803/EnM.2015.30.1.47

Abstract

No abstract available.

Reference

1. Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. Endocrinol Metab. 2014; 29:20–29.

2. Kim JG. Molecular pathogenesis and targeted therapies in well-differentiated thyroid carcinoma. Endocrinol Metab. 2014; 29:211–216.

3. Kim TY, Kim WG, Kim WB, Shong YK. Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab. 2014; 29:217–225.

4. Chai YJ, Lee KE, Youn YK. Can robotic thyroidectomy be performed safely in thyroid carcinoma patients? Endocrinol Metab. 2014; 29:226–232.

5. Chung JK, Cheon GJ. Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. Endocrinol Metab. 2014; 29:233–239.

6. Sun X, Shan Z, Teng W. Effects of increased iodine intake on thyroid disorders. Endocrinol Metab. 2014; 29:240–247.

7. Jeon EJ, Jung ED. Diagnostic whole-body scan may not be necessary for intermediate-risk patients with differentiated thyroid cancer after low-dose (30 mCi) radioactive iodide ablation. Endocrinol Metab. 2014; 29:33–39.

8. Lee MW, Shin DY, Kim KJ, Hwang S, Lee EJ. The biochemical prognostic factors of subclinical hypothyroidism. Endocrinol Metab. 2014; 29:154–162.

9. Hyun KR, Kang S, Lee S. Cost-of-illness trends associated with thyroid disease in Korea. Endocrinol Metab. 2014; 29:257–269.

10. Son JI, Rhee SY, Woo JT, Park WS, Byun JK, Kim YJ, Byun JM, Chin SO, Chon S, Oh S, Kim SW, Kim YS. Insufficient experience in thyroid fine-needle aspiration leads to misdiagnosis of thyroid cancer. Endocrinol Metab. 2014; 29:293–299.

11. Sanjari M, Gholamhoseinian A, Nakhaee A. The association between cobalt deficiency and endemic goiter in school-aged children. Endocrinol Metab. 2014; 29:307–311.

12. Canete EJ, Sison-Pena CM, Jimeno CA. Clinicopathological, biochemical, and sonographic features of thyroid nodule predictive of malignancy among adult Filipino patients in a tertiary hospital in the Philippines. Endocrinol Metab. 2014; 29:489–497.

13. Hong AR, Lim JA, Kim TH, Choi HS, Yoo WS, Min HS, Won JK, Lee KE, Jung KC, Park do J, Park YJ. The frequency and clinical implications of the BRAF(V600E) mutation in papillary thyroid cancer patients in Korea over the past two decades. Endocrinol Metab. 2014; 29:505–513.

14. Choi YM, Kim TY, Jang EK, Kwon H, Jeon MJ, Kim WG, Shong YK, Kim WB. Standardized thyroid cancer mortality in Korea between 1985 and 2010. Endocrinol Metab. 2014; 29:530–535.

15. Jung MJ, Kwon SK. Expression of glucagon-like Peptide-1 receptor in papillary thyroid carcinoma and its clinicopathologic significance. Endocrinol Metab. 2014; 29:536–544.

16. Kim JH, Kim NK, Oh YL, Kim HJ, Kim SY, Chung JH, Kim SW. The validity of ultrasonography-guided fine needle aspiration biopsy in thyroid nodules 4 cm or larger depends on ultrasonography characteristics. Endocrinol Metab. 2014; 29:545–552.

17. Lim S. Ectopic fat assessment focusing on cardiometabolic and renal risk. Endocrinol Metab. 2014; 29:1–4.

18. Kojima I, Nakagawa Y, Ohtsu Y, Medina A, Nagasawa M. Sweet taste-sensing receptors expressed in pancreatic beta-cells: sweet molecules act as biased agonists. Endocrinol Metab. 2014; 29:12–19.

19. Bae KH, Kim JG, Park KG. Transcriptional regulation of fibroblast growth factor 21 expression. Endocrinol Metab. 2014; 29:105–111.

20. Lee JH, Choi Y, Jun C, Hong YS, Cho HB, Kim JE, Lyoo IK. Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab. 2014; 29:112–121.

21. Son YH, Ka S, Kim AY, Kim JB. Regulation of adipocyte differentiation via microRNAs. Endocrinol Metab. 2014; 29:122–135.

22. Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, Kim EM, Suh SH, Shin HJ, Lee KR, Lee KY, Lee SY, Lee SY, Lee SK, Lee CB, Chung S, Jeong IK, Hur KY, Kim SS, Woo JT. Committee of Clinical Practice Guidelines; Korean Society for the Study of Obesity. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab. 2014; 29:405–409.

23. Jeon WS, Park CY. Antiobesity pharmacotherapy for patients with type 2 diabetes: focus on long-term management. Endocrinol Metab. 2014; 29:410–417.

24. Yoon YS, Oh SW. Optimal waist circumference cutoff values for the diagnosis of abdominal obesity in Korean adults. Endocrinol Metab. 2014; 29:418–426.

25. Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab. 2014; 29:427–434.

26. Han HS, Choi D, Choi S, Koo SH. Roles of protein arginine methyltransferases in the control of glucose metabolism. Endocrinol Metab. 2014; 29:435–440.

27. Chae HB, Lee SY, Kim NH, Han KJ, Lee TH, Jang CM, Yoo KM, Park HJ, Lee MK, Jeon WS, Park SE, Moon HS, Park CY, Lee WY, Oh KW, Park SW, Rhee EJ. Age is the strongest effector for the relationship between estimated glomerular filtration rate and coronary artery calcification in apparently healthy Korean adults. Endocrinol Metab. 2014; 29:312–319.

28. Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab. 2014; 29:443–449.

29. Jeong DW, Lee HW, Cho YH, Yi DW, Lee SY, Son SM, Kang YH. Comparison of serum ferritin and vitamin d in association with the severity of nonalcoholic Fatty liver disease in Korean adults. Endocrinol Metab. 2014; 29:479–488.

30. Han KJ, Lee SY, Kim NH, Chae HB, Lee TH, Jang CM, Yoo KM, Park HJ, Lee MK, Jeon WS, Park SE, Park CY, Lee WY, Oh KW, Park SW, Rhee EJ. Increased risk of diabetes development in subjects with the hypertriglyceridemic waist phenotype: a 4-year longitudinal study. Endocrinol Metab. 2014; 29:514–521.

31. Suh S, Baek J, Bae JC, Kim KN, Park MK, Kim DK, Cho NH, Lee MK. Sex factors in the metabolic syndrome as a predictor of cardiovascular disease. Endocrinol Metab. 2014; 29:522–529.

32. Fukumoto S. Diagnostic modalities for FGF23-producing tumors in patients with tumor-induced osteomalacia. Endocrinol Metab. 2014; 29:136–143.

33. Lee HJ, Lee J. Differential diagnosis of adrenal mass using imaging modality: special emphasis on f-18 fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography. Endocrinol Metab. 2014; 29:5–11.

34. Lee MJ, Ryu HK, An SY, Jeon JY, Lee JI, Chung YS. Testosterone replacement and bone mineral density in male pituitary tumor patients. Endocrinol Metab. 2014; 29:48–53.

35. Lee DM, Yu SH, Yoon HH, Lee KL, Eom YS, Lee K, Kim BJ, Kim YS, Park Ie B, Kim KW, Lee S. Genetic analysis of multiple endocrine neoplasia type 1 (MEN1) leads to misdiagnosis of an extremely rare presentation of intrasellar cavernous hemangioma as MEN1. Endocrinol Metab. 2014; 29:146–153.

36. Chung YJ, Hwang S, Jeong JJ, Song SY, Kim SH, Rhee Y. Genetic and epigenetic analysis in Korean patients with multiple endocrine neoplasia type 1. Endocrinol Metab. 2014; 29:270–279.

37. Lee Y, Ku CR, Kim EH, Hong JW, Lee EJ, Kim SH. Early prediction of long-term response to cabergoline in patients with macroprolactinomas. Endocrinol Metab. 2014; 29:280–292.

38. Kim JS, Kim BS, Jeon JY, Choi YJ, Chung YS. Testosterone deficiency associated with poor glycemic control in Korean male diabetics. Endocrinol Metab. 2014; 29:300–306.

39. Park JY, Kim JH, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim KW. Using growth hormone levels to detect macroadenoma in patients with acromegaly. Endocrinol Metab. 2014; 29:450–456.

40. Kim BY, Chun AR, Kim KJ, Jung CH, Kang SK, Mok JO, Kim CH. Clinical characteristics and metabolic features of patients with adrenal incidentalomas with or without subclinical Cushing's syndrome. Endocrinol Metab. 2014; 29:457–463.

41. Cho E, Chang JM, Yoon SY, Lee GT, Ku YH, Kim HI, Lee MC, Lee GH, Kim MJ. Preoperative localization and intraoperative parathyroid hormone assay in Korean patients with primary hyperparathyroidism. Endocrinol Metab. 2014; 29:464–469.

42. Park SM, Bae JC, Joung JY, Cho YY, Kim TH, Jin SM, Suh S, Hur KY, Kim KW. Clinical characteristics, management, and outcome of 22 cases of primary hypophysitis. Endocrinol Metab. 2014; 29:470–478.

43. Ahn CH, Kim LK, Lee JE, Jung CH, Min SH, Park KS, Kim SY, Cho YM. Clinical implications of various criteria for the biochemical diagnosis of insulinoma. Endocrinol Metab. 2014; 29:498–504.

44. Hong JM, Park CS, Nam-Goong IS, Kim YS, Lee JC, Han MW, Choi JI, Kim YI, Kim ES. Curcumin enhances docetaxel-induced apoptosis of 8505C anaplastic thyroid carcinoma cells. Endocrinol Metab. 2014; 29:54–61.

45. Kim E, Seok HH, Lee SY, Lee DR, Moon J, Yoon TK, Lee WS, Lee KA. Correlation between expression of glucose transporters in granulosa cells and oocyte quality in women with polycystic ovary syndrome. Endocrinol Metab. 2014; 29:40–47.

46. Hwang M, Lee JM, Kim Y, Geum D. Functional role of parkin against oxidative stress in neural cells. Endocrinol Metab. 2014; 29:62–69.

47. Jeon YK, Kim WJ, Shin MJ, Chung HY, Kim SS, Kim BH, Kim SJ, Kim YK, Kim IJ. Short-term caloric restriction does not reduce bone mineral density in rats with early type 2 diabetes. Endocrinol Metab. 2014; 29:70–76.

48. Kim JW, Kim HS, Kim SD, Park JY. Insulin phosphorylates tyrosine residue 464 of tub and translocates tubby into the nucleus in HIRcB cells. Endocrinol Metab. 2014; 29:163–168.

49. Lee JH, Kim JY, Jahng JW. Highly palatable food during adolescence improves anxiety-like behaviors and hypothalamic-pituitary-adrenal axis dysfunction in rats that experienced neonatal maternal separation. Endocrinol Metab. 2014; 29:169–178.

50. Kim DG, Yoo JC, Kim E, Lee YS, Yarishkin OV, Lee da Y, Lee KH, Hong SG, Hwang EM, Park JY. A novel cytosolic isoform of mitochondrial trans-2-enoyl-CoA reductase enhances peroxisome proliferator-activated receptor alpha activity. Endocrinol Metab. 2014; 29:185–194.

51. Kim HY, Hwang JI, Moon MJ, Seong JY. A novel long-acting glucagon-like peptide-1 agonist with improved efficacy in insulin secretion and beta-cell growth. Endocrinol Metab. 2014; 29:320–327.

52. Seong I, Kim J. Gene expression regulation by agonist-independent constitutive signaling of melanocortin-1 receptor. Endocrinol Metab. 2014; 29:179–184.

53. Cheon SH, Yan BC, Chen BH, Park JH, Ahn JH, Kim IH, Lee JC, Park YS, Kim MJ, Lee YL, Cho JH, Won MH. Accelerated and exacerbated effects of high dietary fat on neuronal damage induced by transient cerebral ischemia in the gerbil septum. Endocrinol Metab. 2014; 29:328–335.

54. Park SJ, Chung YH, Lee JH, Dang DK, Nam Y, Jeong JH, Kim YS, Nabeshima T, Shin EJ, Kim HC. Growth hormone-releaser diet attenuates cognitive dysfunction in klotho mutant mice via insulin-like growth factor-1 receptor activation in a genetic aging model. Endocrinol Metab. 2014; 29:336–348.

55. Lee ES, Kim WR, Kim Y, Lee HW, Kim H, Sun W. Polarized and stage-dependent distribution of immunoreactivity for novel PDZ-binding protein Preso1 in adult neurogenic regions. Endocrinol Metab. 2014; 29:349–355.

56. Yoo SJ, Nakra NK, Ronnett GV, Moon C. Protective effects of inducible HO-1 on oxygen toxicity in rat brain endothelial microvessel cells. Endocrinol Metab. 2014; 29:356–362.

57. Park I, Lee Y, Kim HD, Kim K. Effect of resveratrol, a SIRT1 activator, on the interactions of the CLOCK/BMAL1 complex. Endocrinol Metab. 2014; 29:379–387.

58. Lee JY, Yune TY. Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation. Endocrinol Metab. 2014; 29:371–378.

59. Sha J, Na J, Lee JO, Kim N, Lee SK, Kim JH, Moon JW, Kim SJ, Lee HJ, Choi JI, Park SH, Kim HS. Vav3, a GEF for RhoA, plays a critical role under high glucose conditions. Endocrinol Metab. 2014; 29:363–370.

60. Hong SW, Lee J, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Lee WY. Activation of AMP-activated protein kinase attenuates tumor necrosis factor-alpha-induced lipolysis via protection of perilipin in 3T3-L1 adipocytes. Endocrinol Metab. 2014; 29:553–560.

61. Lee YK, Park I, Lee H. Partial hepatectomy in acetylation-deficient BubR1 mice corroborates that chromosome missegregation initiates tumorigenesis. Endocrinol Metab. 2014; 29:561–566.

62. Jeon YK, Bae MJ, Kim JI, Kim JH, Choi SJ, Kwon SK, An JH, Kim SS, Kim BH, Kim YK, Kim IJ. Expression of glucagon-like peptide 1 receptor during osteogenic differentiation of adipose-derived stem cells. Endocrinol Metab. 2014; 29:567–573.

63. Jo HJ, Kim YH, Shin DH, Kim MJ, Lee SJ, Jeon DO, Im SG, Jang SK, Choi JY. Hyponatremia after thyroid hormone withdrawal in a patient with papillary thyroid carcinoma. Endocrinol Metab. 2014; 29:77–82.

64. Eun CR, Ahn JH, Seo JA, Kim NH. Pheochromocytoma with markedly abnormal liver function tests and severe leukocytosis. Endocrinol Metab. 2014; 29:83–90.

65. Jeong HK, An JH, Kim HS, Cho EA, Han MG, Moon JS, Kim HK, Kang HC. Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis. Endocrinol Metab. 2014; 29:91–95.

66. Choi HS, Kim MJ, Moon CH, Yoon JH, Ku HR, Kang GW, Na , II , Lee SS, Lee BC, Park YJ, Kim HI, Ku YH. Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome. Endocrinol Metab. 2014; 29:96–100.

67. Kang YE, Hong JH, Kim J, Joung KH, Kim HJ, Ku BJ, Kim KS. A novel PHEX gene mutation in a patient with sporadic hypophosphatemic rickets. Endocrinol Metab. 2014; 29:195–201.

68. Lee SW, Lee EK, Yun T, Won YW, Ko EJ, Choi M, Choi SI, Park SS, Hong EK. Recurrent hypoglycemia triggered by sorafenib therapy in a patient with hemangiopericytoma. Endocrinol Metab. 2014; 29:202–205.

69. Yun KJ, Kim W, Kim EH, Kim MH, Lim DJ, Kang MI, Cha BY. Accelerated disease progression after discontinuation of sorafenib in a patient with metastatic papillary thyroid cancer. Endocrinol Metab. 2014; 29:388–393.

70. Choi JE, Lee HR, Ohn JH, Moon MK, Park J, Lee SJ, Choi MG, Yoo HJ, Kim JH, Hong EG. Adult multisystem langerhans cell histiocytosis presenting with central diabetes insipidus successfully treated with chemotherapy. Endocrinol Metab. 2014; 29:394–399.

71. Kwon H, Kim H, Park S, Song DE, Kim WG, Kim TY, Shong YK, Kim WB. Solitary skin metastasis of papillary thyroid carcinoma. Endocrinol Metab. 2014; 29:579–583.

72. Kim JK, Kim BH, Baek SM, Shin DH, Kim WJ, Jeon YK, Kim SS, Kim IJ. Incidentally detected inoperable malignant pheochromocytoma with hepatic metastasis treated by transcatheter arterial chemoembolization. Endocrinol Metab. 2014; 29:584–589.